Nephrin (NPHS1) has been described as an important structural protein of kidney podocytes. Mutations in this gene lead to the Finnish-type congenital nephrotic syndrome. More recently, a role of nephrin as a signalling molecule in kidney podocytes has been identified. Here, we show that nephrin not only has a function in kidney podocytes, but is also required for cardiovascular development. Nephrin is expressed in the epicardium and coronary vessels during human and mouse embryonic development. Nephrin knockout embryos showed abnormal epicardial cell morphology and, at later stages of development, a reduced number of coronary vessels due to increased apoptosis, and in addition, cardiac fibrosis. Connexin 43, which is required for coronary vessel formation, was downregulated in nephrin knockout embryos. Expression of the p75NTR neurotrophin receptor, a known mediator of apoptosis, was increased in mutants. Furthermore, co-immunoprecipitation studies demonstrated a direct interaction of nephrin with p75NTR. Primary nephrin-deficient cardiac cells showed a 5-fold higher rate of apoptosis in response to progenitor of nerve growth factor compared with wild-type cells, which could be rescued by RNAi against p75NTR. Taken together, our data demonstrate that nephrin directly interacts with p75NTR and reveal an important role for nephrin in murine cardiac development by permitting survival of cardiovascular progenitor cells.
INTRODUCTION
Nephrin is a transmembrane protein of the immunoglobulin superfamily that functions as an adhesion molecule and structural component of the glomerular slit diaphragm in the kidney (1, 2) . More recently, it was shown that nephrin can also act as a signalling molecule and several physiological interaction partners have been identified. It has been demonstrated that Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes, which is required for nephrin-dependent reorganization of actin (3) . Interactions of nephrin with CD2AP, podocin, adherens junction proteins, Fyn, phosphoinositide 3-OH kinase, dendrin and vascular endothelial growth factor (VEGF) have also been described (4 -10) . Functional consequences of these interactions remain largely obscure, but prevention of programmed cell death (apoptosis) was attributed to the binding of nephrin to dendrin and VEGF (9, 10) . Besides kidney podocytes, activity of nephrin promoter elements has been described in the brain, spinal cord and pancreas (11, 12) . Nephrin shows a very restricted expression pattern with one study reporting exclusive expression within kidney glomeruli (13) . More recent analyses, however, suggest additional sites of expression outside of the kidney, including human lymphoid tissues, pancreatic islet endothelial and beta cells (14 -16) .
The neonatal lethality of nephrin knockout mice (17) and the severely reduced number of knockout embryos we already obtained in the midgestation period (see below) prompted us to investigate other possible pathologies besides the known kidney phenotype.
We show here that nephrin is expressed during human and mouse embryonic cardiac development. Employing the published nephrin knockout mouse model (17) , we further demonstrate that nephrin serves a crucial function in cardiac vessel development.
RESULTS

Nephrin is expressed during cardiac development
We used a combination of immunohistochemistry, in situ hybridization, western blot, immuno-electron microscopy and transgenic reporter mice to demonstrate expression of nephrin in the heart during embryonic development. Immunostaining at embryonic day 12.5 (E12.5) evidenced expression within the epicardium and the developing coronary vessels (Fig. 1A) . At later stages of development, nephrin was localized in the epicardium and to a lower extent in the endothelial layer of developing coronary vessels ( Fig. 1B and C) , whereas in the adult mouse heart, the protein was detectable only in some patches of epicardium and a few intracardiac blood vessels (Fig. 1D, arrow) . Immunostaining for nephrin in the adult kidney served as a positive control (Fig. 1E) . In situ hybridization with an antisense probe at E12.5, E15.5 and E18.5 confirmed the results obtained by immunohistochemistry (Supplementary Material, Fig. S1 ). To test whether expression of nephrin in the heart is conserved between species, we next analysed human hearts obtained from embryos with non-cardiac causes of intrauterine death. Nephrin was detectable in the epicardium at 23 weeks of gestation, the earliest time point available to us. At 30 weeks of gestation, nephrin was mostly expressed in cardiac vascular endothelial cells (Supplementary Material, Fig. S2A ). Immuno-electron microscopy at E12.5 mouse hearts confirmed low, but consistent nephrin expression in the epicardial cell membrane and to some extent in the Golgi apparatus (Supplementary Material, Fig. S2B ). Quantification of nephrin protein expression by western blotting showed comparable expression levels in the heart during several stages of embryonic development (Supplementary Material, Fig. S2C ). Finally, lacZ reporter analysis in transient transgenic animals with a 6.2 kb fragment upstream of nephrin confirmed the existence of heart-specific regulatory elements in the nephrin promoter (Supplementary Material, Fig. S2D ). Taken together, these data demonstrate that nephrin is expressed in the developing heart, where it is mainly detectable in the epicardium and the developing coronary vessels.
Nephrin is required for normal epicardial development
To investigate the function of nephrin in the heart, we analysed the cardiac phenotype of nephrin-deficient embryos. At E12.5, we detected partial epicardial defects compared with wild-type littermates, which were characterized by the striking spheroid appearance of epicardial cells instead of the normal flattened morphology (n ¼ 4, each, Fig. 2A ). This was confirmed ultrastructurally by electron microscopy, where disruption of cell-to-cell contacts could also be observed (Fig. 2B) . Defects in cellular interactions were demonstrated as well by reduced expression of the major gap-junction protein connexin 43. Immunohistochemical analysis confirmed that the majority of epicardial cells were devoid of connexin 43 expression (Fig. 3A) , which was determined on the molecular level by reduced connexion 43 expression in quantitative reverse transcription polymerase chain reactions (RT-PCRs) (Fig. 3B) . Although epicardial cells showed this abnormal morphology, the epicardial cell layer as such persisted in knockout embryos, as demonstrated by the expression of the specific markers Raldh (Aldh1a2) and Wilms' tumour suppressor (WT1) (Supplementary Material, Figs 3 and 4A).
As connexin 43 is involved in normal coronary vasculogenesis (18, 19) , we next tested whether the initial step of coronary vessel formation (delamination of epicardial cells and migration into the myocardium) occurs in nephrin (2/2) embryos. Indeed, WT1-positive epicardial cells migrating into the myocardium were detected in both nephrin (+/+) and (2/2) embryos at E12.5 (Fig. 4A) . Surprisingly, WT1 expression was almost completely lost at E15.5 in nephrindeficient hearts (Fig. 4B ). Using quantitative RT-PCR, we confirmed comparable Wt1 expression levels in the hearts at E12.5 and a severe reduction at E15.5 (Fig. 4C) . The abnormal cellular morphology in nephrin (2/2) embryos was associated with an increased number of apoptotic [terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)-positive] cells predominantly in the developing epicardium. Apoptosis was associated with increased expression of the low affinity neurotrophin receptor p75NTR (Fig. 5) , which is known to mediate programmed cell death (reviewed in 20).
Nephrin is involved in coronary vessel formation
In normal heart development, a subset of delaminated epicardial cells differentiates into coronary vessels; we wanted to test whether this process may be affected by the loss of nephrin expression. At E15.5, coronary vessel formation in nephrin (2/2) embryos was severely disturbed, with a reduced number of detectable coronary vessels (arrows in Fig. 6D versus C) . This was confirmed by a dramatic reduction in Pecam-1 expression (CD31, platelet endothelial cell adhesion molecule-1), a marker for proliferating endothelial cells (Fig. 7) . Probably, as a consequence of the reduced coronary vessel density and subsequent hypoxia in the cardiac tissue, hypoxia-inducible factor 1 (Hif-1) protein expression was increased in nephrin (2/2) hearts at E15.5 (Supplementary Material, Fig. S4A ). At E15.5, expression of p75NTR was upregulated in the epicardium and extended to developing coronary vessels in nephrin (2/2) hearts (Supplementary Material, Fig. S4B ). Apoptotic cell death was significantly increased in nephrin (2/2) hearts compared with wild-type littermates at E15.5 and extended to epicardial cells, developing coronary vessels, as well as cardiomyocytes (Supplementary Material, Fig. S4C ). The increased apoptosis and higher p75NTR expression were not restricted to the heart, but could be also detected in the kidneys of nephrin (2/2) animals (Supplementary Material, Fig. S5 ). TUNEL staining combined with immunofluorescent labelling of synaptopodin as a marker for podocytes indicated that the majority of apoptotic cells in the kidney of nephrin (2/2) animals were indeed podocytes, although also other kidney cells showed increased apoptosis (Supplementary Material, Fig. S5 ).
In late gestation (E18.5), the number of coronary vessels was reduced in nephrin (2/2) hearts compared with wild-type littermates ( Fig. 8 and Supplementary Material, Movies S1-S3). Despite the activity of the nephrin:LacZ Figure 1 . Nephrin is expressed in the murine heart. Expression of nephrin in the embryonic heart at E12.5 (A), E15.5 (B), E18.5 (C), the adult heart (D) and the adult kidney (E). Note expression of nephrin in the epicardium and the coronary vessels (black arrows). Staining of kidney podocytes served as positive control. Scale bars indicate 50 mm.
reporter construct in the aortic outflow tract of transgenic mice (Supplementary Material, Fig. S2D ), we did not detect gross abnormalities in the morphology of aorta and pulmonary trunk or cardiac valves (Fig. 8A) . A reduced number of intramyocardial blood vessels in nephrin (2/2) hearts compared with wild-type controls was evident in haematoxylineosin-stained sections (Fig. 8B ). This finding was confirmed by significantly reduced immunostaining for Pecam-1 in the myocardium. Endocardial Pecam-1 expression served as internal positive control (Fig. 8C ). In addition, the hearts were in part ischaemic (arrows in Fig. 8B and D) and showed a high number of TUNEL-positive cells throughout the hearts (Supplementary Material, Fig. S6A ). Ultrastructural examination evidenced collagen accumulation and cardiomyocyte degeneration at E18.5 (Supplementary Material, Fig. S6B ). Collagen accumulation leading to cardiac fibrosis was confirmed by Sirius Red staining of collagen fibres (Supplementary Material, Fig. S6C ). Cardiac fibrosis might be the result of Hif-1 activation observed already earlier during embryonic development (21) . In addition, we determined an increased heart-to-body-weight ratio in nephrin (2/2) hearts compared with wild-type littermates at E18.5 (7.2 + 0.2 versus 5.8 + 0.4 mg/g, n ¼ 10, each, P , 0.05), which might indicate cardiac hypertrophy. In agreement with the severity of the cardiac phenotype developing between E12.5 and E18.5, we obtained 31 knockouts out of 129 embryos at E12.5 (24%), 69 knockouts out of 383 embryos at E15.5 (18%) and 64 knockouts out of 357 embryos at E18.5 (18%), suggesting that approximately one quarter of knockout embryos die between E12.5 and E15.5.
Interaction between nephrin and p75NTR
As p75NTR function depends on the association with different interaction partners (reviewed in 20), we speculated that nephrin might interact with p75NTR to prevent apoptosis. To test this hypothesis, we first analysed whether both proteins are expressed in the same cell type. Immunofluorescent analysis demonstrated that nephrin and p75NTR share an overlapping expression pattern in the hearts of wild-type embryos (Fig. 9A ). In addition, as already observed by immunohistochemistry, p75NTR was significantly upregulated on the RNA (Fig. 9B ) and protein level ( Since nephrin and p75NTR are both transmembrane proteins, we next tested for a potential direct interaction of both proteins on the molecular level using co-immunoprecipitation experiments in embryonic cardiac lysates. Strikingly, p75NTR could be co-immunoprecipitated in cardiac lysates using an anti-nephrin antibody, but not in samples incubated with normal serum (Fig. 9D ). To confirm the interaction of p75NTR with nephrin, we next employed mammalian twohybrid analysis using U20S osteosarcoma cells, which do not express endogenous nephrin. A schematic representation of the assay principle and constructs used is provided in Supplementary Material, Figure S7 . As a positive control for the two-hybrid analysis we first used Nck1, a known interaction partner of nephrin (3). Co-transfection of Nck1 and wild-type nephrin expression construct induced reporter activity 5-fold (Fig. 9E , compare Bar1 and Bar 6). Strikingly, co-transfection of the mouse (Bar 2) or human nephrin (Bar 3) together with a p75NTR expression construct led to an 10-fold increase of reporter activity, thus corroborating our hypothesis of direct interaction between these two proteins. Interestingly, introducing the Fin major mutation (nt121del2) (11) into the human nephrin construct did not significantly affect the binding to p75NTR (Bar 4). Since this mutation causes a frameshift in nephrin coding sequence, our results might suggest that p75NTR interacts with the peptide region of nephrin encoded by exons 1 and 2. In agreement with this hypothesis, deletion of the N-terminus from the human nephrin construct abolished activation of the reporter system (Bar 5).
p75NTR induces apoptosis when homodimerizing in the presence of sortilin (22, 23) , whereas interaction with the neurotrophin receptor TrkA promotes cell survival. No changes of sortilin expression were detected between wild-type and nephrin (2/2) hearts (Fig. 9F) . In contrast, TrkA appeared to be slightly downregulated (Fig. 9G) , which is in agreement with the activation of a pro-apoptotic pathway in nephrin knockout hearts. However, expression of TrkB and brainderived neurotrophic factor was not significantly different between wild-type and nephrin (2/2) hearts (data not shown).
To test whether p75NTR is directly involved in the observed increase in apoptosis in nephrin knockout hearts, we performed RNAi silencing experiments on primary cells isolated from the hearts of E12.5 wild-type and knockout embryos. As expected, nephrin could be detected by western blot analysis in the wild-type, but not knockout cells, regardless whether p75NTR was silenced or not (Fig. 9H, upper panel) . Lentiviral RNAi reduced p75NTR protein expression in wild-type and nephrin knockout cardiac primary cells to a comparable degree of 25% of controls (Fig. 9H, middle panel) . Exposure of nephrin-deficient cells to progenitor of nerve growth factor (proNGF), the pro-apoptotic ligand for p75NTR, resulted in a 10-fold higher induction of the number of TUNEL-positive cells, when compared with wild-type controls ( Fig. 9I and J) . Importantly, silencing of p75NTR reduced the number of apoptotic wild-type control cardiac cells only slightly, but diminished significantly the number of apoptotic cells deficient of nephrin ( Fig. 9I and J) .
DISCUSSION
Coronary vessel formation is accomplished through a series of tightly regulated events. First, epicardial cells undergo an epithelial-to-mesenchymal transformation (24) (25) (26) to form subepicardial mesenchymal cells, which connect the epicardium to the myocardium. The subepicardial mesenchymal cells then migrate into the myocardium, where they contribute to endothelial cells, smooth muscle cells and perivascular fibroblasts of the coronary vessels (26, 27) . Further steps in the coronary vessel formation include stabilization of the newly formed vessels and remodelling to connect the vessels to the main coronary arteries, which originate from the aorta (reviewed in 28). This model of coronary vessel formation is widely accepted and supported by a broad variety of genetic models (reviewed in 29), but was questioned recently by a study suggesting that coronary arteries might arise from the sinous venosus (30) . The WT1 has been described as one key regulator in coronary vessel development (31) (32) (33) (34) . We and others reported previously that WT1 activates the protein nephrin in podocytes of the kidney (35, 36) . Here, we have shown that nephrin is also expressed in the developing heart. The fact that nephrin follows the expression of Wt1 in the heart and indeed is absent from Wt1 knockout hearts (data not shown) suggests that WT1 also transcriptionally regulates the nephrin promoter in this tissue. The expression pattern of nephrin has been studied in detail and, apart from the kidney (13), expression in the pancreas (12,14,17), brain and spinal cord (12, 17) and lymphoid tissues (15) has been reported. Thus, it seems surprising that heart-specific expression of this gene has not been identified earlier, in particular when considering that similar lacZ reporter studies as reported here have been carried out before (12) . Part of this may be explained by species-specific differences in the developmental timing of nephrin expression or reflect different experimental conditions and staining procedures. Moreover, the epicardium represents a single-cell-layered mesothelial structure and staining may have been missed in earlier analyses. Whatever the reason, our western blot analyses from embryonic mouse hearts at different stages of development clearly support the notion of substantial nephrin protein expression in the heart.
To investigate a potential function of nephrin in the heart, we used established nephrin knockout animals (17) . As the formation of interconnected vascular tubes in the subepicardial space begins at E11.5 and the coronary vessels connect to the systemic circulation by approximately E14.5 (reviewed in 29), we investigated nephrin knockout animals at E12.5 and E15.5 when these important steps are accomplished. In addition, we analysed embryos at E18.5, the latest possible time point were we obtained viable embryos. At E12.5, mutant mice showed abnormal epicardial morphology, which on the ultrastructural level resembled nephrin-deficient podocytes with spheroidal morphology and a loss of cell-to-cell contacts. The loss of cell contacts was confirmed by a significant reduction in connexin 43 expression. The decrease in connexion 43 expression might be directly attributed to the loss of nephrin, as it has been shown that nephrin stimulates Phosphatidylinositol 3-kinase (PI3K)/Akt signalling (37) and PI3K/Akt is required to maintain steady-state expression of connexion 43 (38) . The lack of connexin 43 expression was already associated earlier with an abnormal epicardial cell morphology (18) . Interestingly, connexin 43-deficient mice had also an increased rate of apoptosis in the myocardium and a dysregulation of coronary vasculogenesis (18) . Nevertheless, the cardiac phenotype of nephrin knockout embryos cannot be fully attributed to reduced connexin 43 expression, as connexin 43-deficient embryos show a slightly different cardiac phenotype (18) . Therefore, we also investigated the neurotrophin receptor system as a known critical regulator in the formation of the heart and of vascular development (reviewed in 39).
Several lines of evidence suggest that physical interaction of nephrin with the p75NTR and additional upregulation of p75NTR are critically involved in the cardiac phenotype of nephrin-deficient embryos. First, nephrin and p75NTR share a partial overlapping expression pattern in the epicardium and subepicardial coronary vessels. Secondly, nephrin and p75NTR bind to each other in the heart in co-immunoprecipitation experiments in vivo. As it has been shown that p75NTR promotes cell survival when forming heterodimers, but induces apoptosis when homodimerizing in the presence of proNGF (reviewed in 20, 40) , the lack of nephrin might be in favour of a pro-apoptotic pathway. Thirdly, we confirmed physical interaction of nephrin with the p75NTR in mammalian two-hybrid assays. Interestingly, introducing the Finn major mutation (11) into the human nephrin construct did not significantly affect binding to nephrin, which may suggest that p75NTR binds to amino acids encoded by exons 1 and 2 of nephrin. Accordingly, deletion of the N-terminus from the nephrin expression construct abolished activation of the reporter system. Finally, isolated cardiac cells from nephrin-deficient embryos showed an 10-fold higher degree of apoptosis in response to proNGF, which could be rescued completely by silencing of p75NTR. Although these data are in agreement with a pro-apoptotic effect of p75NTR (reviewed in 39), there are also some reports suggesting a role of p75NTR in survival of vascular cells (41, 42) .
The lack of nephrin resulted in an additional increase in p75NTR mRNA and protein levels in the developing heart, whereas the neurotrophin receptor TrkA was slightly downregulated and sortilin showed no significant change. p75NTR in the presence of sortilin provokes apoptosis in response to proNGF (23) , whereas TrkA stimulation prevents apoptosis (reviewed in 20,39). Thus, the observed expression changes are in good agreement with an increase in apoptosis. Increased expression of p75NTR and higher apoptosis could be also detected in the kidneys of nephrin knockout embryos. Increased apoptosis in tubules in nephrin-deficient animals had been reported earlier, whereas glomerular apoptosis was not detected (43) , which might be due to methodological differences. p75NTR expression in the mesenchyme and developing glomeruli of the kidney has been reported earlier (37, 44, 45) .
While the induction of p75NTR, the activation of Hif-1 (46) and the loss of connexin 43 (18) may all contribute to apoptosis of cardiovascular cells, we also observed a high number of apoptotic cells in the deep myocardium. As we did not detect expression of any of these proteins in this tissue, it is likely that other factors may contribute to apoptosis in nephrindeficient embryos.
The cardiovascular phenotype of nephrin-deficient embryos is in seeming contrast to the human situation. Although not widely known, cardiac abnormalities have been reported in FinMajor mutation patients, which presented mainly with mild cardiac hypertrophy (47) . This is in agreement with the increased heart-to-body-weight ratio we measured in nephrin-deficient embryos. As in the above-mentioned report, no cardiac angiograms were performed; it is also possible that subclinical alterations in cardiac vessel formation might exist in these patients.
Taken together, we demonstrate an important and unexpected role of nephrin for murine cardiac development by permitting survival of embryonic cardiac cells. Taking into account the expression of podocalyxin (48), WT1 (32, 33) and nephrin in cardiac vascular cells, as well as the potential link of podocin mutations with heart disease in human patients (49) , it is tempting to speculate that 'podocyte-specific' proteins may have a more general role in cardiac vessel development.
MATERIALS AND METHODS
Animals
Heterozygous mouse breeding pairs (FVBN genetic background) for the Nphs1 knockout allele were genotyped by PCR as described (17) . Most of the Nphs12/2 mice died at end-gestation or immediately after birth.
Transient transgenic animals expressing a LacZ reporter under control of 6.2 kb nephrin regulatory sequence (12) were generated by pronuclear microinjection into fertilized mouse oocytes according to the established procedures (31) . Transgenic embryos were obtained at E13.5 (the day of vaginal plug was considered E0.5) and identified by PCR as described (12) . LacZ staining was performed on whole embryos according to the protocol by Hogan et al. (50) as described in detail elsewhere (35) . Afterwards, the embryos were post-fixed and sections cut to 150 mm on a vibratome.
Real-time RT -PCR
RT-PCR was performed with 2 mg of total RNA as described elsewhere (32) . Real-time PCR was performed on the Light Cycler Instrumentw (Roche, Meylan, France) using the Platinumw SYBRw Green kit (Invitrogen, Cergy Pontoise, France). The following primers were used for PCR amplification: mouse Nphs1 (accession no. NM_019459), 5
′ (reverse primer). Expression was normalized to the individual levels of the housekeeping gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (accession no.
Mammalian two-hybrid assays
The mammalian two-hybrid assays were performed according to the manufacturer's instructions (Agilent Technologies, Massy, France). U2OS cells were co-transfected with twohybrid constructs, a luciferase expressing construct (pFR-Luc, Agilent Technologies) and a beta-galactosidase construct under a cytomegalie virus (CMV) promoter (pCMVb, Clontech, Saint-Germain-en-Laye, France) using Fugene 6w (Roche). The luciferase was normalized to co-transfected galactosidase activity. The Finn major mutation was introduced into the human nephrin cDNA construct using the QuikChange II site-directed mutagenesis kit (Agilent Technologies). As a positive control, the published murine nephrin interaction partner Nck1 (3) cDNA was amplified by PCR using the following primers: 5 ′ -ATTAATCCCGGGATGGCTGAAGTGGTGGTGGTG-3 ′ (forward); 5-TAAGGGCCCTAAAGCTGTGGAACAGTCA C-3 ′ (reverse) and subcloned into the ApaI, SmaI restriction sites of the pCMV-BD vector (Agilent Technologies). To investigate the relevance of the N-terminus of human nephrin for binding to p75NTR, the human nephrin construct in the pCMV-AD vector (Agilent Technologies) was digested with EcoRI, re-ligated and sequenced. This deletion construct results in omission of the first 117 amino acids of human nephrin (hnephrinDN). The p75NTR or Nck1 constructs in the pCMV-BD vector were cotransfected with equal amounts of either the mouse or human nephrin constructs or the hnephrinDN or the hnephrinFinn major constructs in the pCMV-AD vector.
Co-immunoprecipitation and sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
For co-immunoprecipitation, E15.5 wild-type hearts were isolated and lysed and immunoprecipitated using 50 mg of either a rabbit anti-nephrin antibody (gift of L.B. Holzman) or normal rabbit serum as described (51) . Electrophoresis and blotting were performed as described (52) . The following antibodies were used for immunodetection: polyclonal anti-p75NTR antibody from rabbit (AB1554, Millipore, 1:500 dilution in phosphate-buffered saline (PBS), 5% Blotto, 0.05% Tween 20) and peroxidase-coupled goat antirabbit secondary antibody (1:5.000 dilution in PBS, 5% Blotto, 0.05% Tween-20, Santa Cruz Biotechnology).
Histology and immunohistochemistry
Morphological studies were performed according to our previously published protocols (53) . Staged mouse embryos were fixed overnight at 48C in paraformaldehyde 4% and either embedded in paraffin or snap-frozen in pre-chilled isopentane and then embedded in tissue-Tek O.C.T. compound (Sakura Finetek). Formalin-fixed, paraffin-embedded human fetal hearts were obtained from the archives of the Department of Pathology (CHU Nice, France). Only samples from noncardiac causes of intrauterine death, and no abortion material, were used. Three micrometre paraffin sections were used for histological and immunohistological investigations. Ten micrometer cryostat sections were cut and transferred onto gelatin-coated glass slides for immunohistological doublelabelling experiments. Collagen-specific Sirius Red (Waldeck Gmbh, Münster, Germany) staining for measurement of interstitial and perivascular fibrosis was performed according to the manufacturer's instruction. Sections were permeabilized with 0.1% Triton X-100 in PBS and blocked by incubation for 1 h in 10% normal serum (in PBS), which was obtained from the same species as the secondary antibody. An indirect immunofluorescence double-labelling technique was used to mark p75NTR and nephrin-expressing cells (35) . Sections were incubated (16 h, 48C) with primary antibodies each diluted 1:100 in PBS, 0.1% Triton X-100, 3% bovine serum albumin (BSA): polyclonal anti-p75NTR antibody from rabbit (cat.# AB1554, Millipore) and polyclonal anti-nephrin antibody from guinea pig (cat.# GP-N2, Progen, Heidelberg, Germany). The reaction products were visualized by incubation (1.5 h at room temperature) with Cy3-and Cy2-conjugates. Counterstaining of the nuclei was done with 4 ′ -6-diamidino-2-phenylindole (Dapi). The slides were viewed under an epifluorescence microscope (DMLB, Leica, Wetzlar, Germany) connected to a digital camera (Spot RT Slider, Diagnostic Instruments, Sterling Heights, USA) with the Spot Software (Diagnostic Instruments).
Alternatively, paraffin sections were stained with a peroxidase technique. To this end, the slides were incubated with guinea pig polyclonal anti-nephrin antibody (cat.# GP-N2, Progen), goat polyclonal anti-PECAM-1 (cat.# sc-1506, Santa Cruz Biotechnology), mouse monoclonal anti HIF-1a (cat.# MAB5382, Millipore), rabbit polyclonal anti-p75NTR (cat.# AB1554, Millipore) or with mouse monoclonal anti-Connexin-43 (cat.# C13720, BD Transduction Laboratories, Le-Pont-de-Claix, France). Antigen detection was performed using the Vector M.O.M. Immunodetection Kit (cat.# PK-2200, Vector Laboratories, CliniSciences, Montrouge, France), or with a biotinylated anti-goat antibody for PECAM-1 (Vector Laboratories), with a biotinylated antiguinea pig antibody for Nephrin (Vector Laboratories) and with a biotinylated anti-rabbit antibody (Vector Laboratories) for Wt1 and p75, followed by incubation with peroxidase-coupled Streptavidin (Sigma-Aldrich, Lyon, France). The reaction was visualized with diaminobenzidine (DAB) substrate (cat.# SK-4100, Vector Laboratories). For PECAM-1 quantification, at least three tissue sections from three different wild-type or nephrin2/2 embryos each were analysed at E15.5.
mRNA in situ hybridization
For in situ hybridization experiments, paraffin sections were cut at 5 mm from staged mouse embryos. Antisense and sense cRNA probes for mouse nephrin (54) and Raldh were transcribed as described with the modification of biotin labelling of the probes (Biotin RNA Labeling Mix, Roche). Prehybridization, hybridization and stringent washes were carried out as described previously (54) . Detection reactions were performed using the GenPoint TM Amplified Detection System (Dako, Trappes, France). Sections were counterstained with haematoxylin (Sigma).
Labelling of apoptotic cells
Apoptotic cells were detected by TUNEL staining using the In situ Cell Death Detection Kit (Roche) according to the manufacturer's instructions. At least three tissue sections from three different wild-type or Nephrin2/2 embryos each were analysed at the indicated time points. For synaptopodin-TUNEL double staining, kidney sections were incubated with an antisynaptopodin antibody (Progen); antigen detection was performed using the Vector M.O.M. Immunodetection Kit; and visualization was achieved with Cy3-coupled Streptavidin (Sigma). The immunohistochemical staining was followed by the detection of fluorescein isothiocyanate (FITC)-positive apoptotic cells using the In situ Cell Death Detection Kit (Roche) according to the manufacturer's instructions.
Electron microscopy and immuno-electron microscopy
Mouse hearts were fixed immediately after dissection in 2.5% glutaraldehyde in 0.1 M phosphate buffer. They were rinsed with buffer and then post-fixed in osmium tetroxide (1%) for 1 h. After rinsing with water, they were dehydrated with acetone and embedded in Epon resin. Eighty-nanometre sections were contrasted with uranyl acetate and lead citrate and then observed in an electron microscope (Philips CM12) operating at 100 kV.
For immuno-electron microscopy, E12.5 embryonic hearts were prepared as described (55) . Briefly, after fixation in 4% paraformaldehyde, 0.3% glutaraldehyde in PBS and rinses in PBS, ventricles were embedded in 10% gelatine. The blocs were then infused 24 h in 2.3 M sucrose for cryoprotection, cut in 1 mm 3 cubes, mounted on aluminium holders and frozen by plunging in liquid nitrogen. Ultrathin cryosections of 70 nm were performed at 21108C on an fetal calf serum (FCS) cryo-chamber (Leica Microsystems) mounted on an Ultracut-S ultramicrotome (Leica Microsystems). Sections were picked up in a 1:1 mixture of 2% methyl cellulose and 2.3 M sucrose and thawed on formvar/carbon-coated nickel grids. The immunogold was processed in an automat (EM IGL, Leica Microsystems) and consisted of: rinses in PBS, 15 min fixative quenching in 150 mM glycine, rinses in PBS, 30 min blocking in 0.1% BSA, 0.1% cold water fish skin gelatine (Aurion), 1 h incubation in primary antibody 1/ 50 in PBS (gift of L.B. Holzman), rinses in PBS, protein-A coupled to 10 nm colloidal gold particles (University Medical Center, Utrecht, NL, USA), rinses in PBS and postfixation in 2.5% glutaraldehyde. A positive -negative staining (56) was performed before observation on a CM12 Philips TEM operated at 80 kV.
Cell culture and transient transfection
For primary cell cultures, embryos were dissected at E12.5, genotyped by PCR as described (17) and the hearts of nephrin (+/+) or (2/2) embryos isolated and minced separately followed by enzymatic digestion with 0.05% Trypsin (Sigma) in serum-free Dulbecco's modified Eagle's medium (DMEM). Digestion was stopped by addition of 10% FCS. Cells were grown in the DMEM medium supplemented with 10% FCS, 100 IU/ml gentamycin (50 mg/ml) and amphotericin B (50 ng/ml). Media and reagents were obtained from Invitrogen. For RNAi experiments (n ¼ 4), cells were seeded in chamber slides or 6 cm dishes (NUNC, VWR International, Fontenay sous Bois, France) and after 3 days transduced with either p75NTR shRNA lentiviral particles (sc-37268-V, Santa Cruz Biotechnology) or control lentiviral particles (sc-108080, Santa Cruz Biotechnology) in the presence of polybrenew (sc-134220, Santa Cruz Biotechnology) according to the manufacturer's instructions. After 12 h, the culture medium was changed and proNGF (2 ng/ml, Milipore) added to the cultures. Forty-eight hours later, the cells were either lysed for protein analyses or the number of apoptotic cells determined by TUNEL labelling.
Optical projection tomography (OPT)
For optical projection tomography (OPT), embryos were dissected at E18.5, genotyped by PCR as described (17) and the hearts of nephrin (+/+) or (2/2) embryos fixed and stained with the PECAM-1 antibody mentioned above. Post-processing and OPT were performed as described (57) using a Bioptonics 3001 system (Bioptonics, Edinburgh, UK). Tissue autofluorescence was used to visualize anatomical structures.
Statistics
Data are expressed as means + SEM. Analysis of variance (ANOVA) with the Bonferroni test as post hoc test was used versus control. Differences between two groups were tested using the Mann -Whitney test for non-parametric samples. A P-value , 0.05 was considered statistically significant.
